Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Santoro

Showing results (101-110 of 201) with videos related to

Pageof 21
Sort By:
Oncogene|March 1, 2005
The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residueIlaria Le Pera, Rodolfo Iuliano, Tullio Florio, et al.
Biochimica Et Biophysica Acta|September 9, 2009
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motifSonia Moretti, Valentina De Falco, Anna Tamburrino, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 13, 2011
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomasLiborio Torregrossa, Riccardo Giannini, Nicla Borrelli, et al.
Thyroid : Official Journal of the American Thyroid Association|October 20, 2011
Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parametersAgnese Proietti, Clara Ugolini, Rosa Marina Melillo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 7, 2006
Prevalence of spinocerebellar ataxia type 2 mutation among Italian Parkinsonian patientsAnna Modoni, Maria Fiorella Contarino, Anna Rita Bentivoglio, et al.
Cancer Research|February 19, 2009
The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferationMaria Domenica Castellone, Valentina De Falco, Deva Magendra Rao, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2007
The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinomaRiccardo Giannini, Clara Ugolini, Cristiana Lupi, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosisDaniela Spalletti-Cernia, Rosanna Sorrentino, Sonia Di Gaetano, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2002
Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growthMaria Luisa Martelli, Rodolfo Iuliano, Ilaria Le Pera, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomasKristian Unger, Horst Zitzelsberger, Giuliana Salvatore, et al.
Pageof 21

Showing results (101-110 of 201) with videos related to

Sort By:
Pageof 21
Oncogene|March 1, 2005
The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residueIlaria Le Pera, Rodolfo Iuliano, Tullio Florio, et al.
Biochimica Et Biophysica Acta|September 9, 2009
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motifSonia Moretti, Valentina De Falco, Anna Tamburrino, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 13, 2011
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomasLiborio Torregrossa, Riccardo Giannini, Nicla Borrelli, et al.
Thyroid : Official Journal of the American Thyroid Association|October 20, 2011
Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parametersAgnese Proietti, Clara Ugolini, Rosa Marina Melillo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 7, 2006
Prevalence of spinocerebellar ataxia type 2 mutation among Italian Parkinsonian patientsAnna Modoni, Maria Fiorella Contarino, Anna Rita Bentivoglio, et al.
Cancer Research|February 19, 2009
The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferationMaria Domenica Castellone, Valentina De Falco, Deva Magendra Rao, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2007
The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinomaRiccardo Giannini, Clara Ugolini, Cristiana Lupi, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosisDaniela Spalletti-Cernia, Rosanna Sorrentino, Sonia Di Gaetano, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2002
Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growthMaria Luisa Martelli, Rodolfo Iuliano, Ilaria Le Pera, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomasKristian Unger, Horst Zitzelsberger, Giuliana Salvatore, et al.
Pageof 21